Literature DB >> 2833960

B19 parvovirus replicates in circulating cells of acutely infected patients.

G J Kurtzman1, P Gascon, M Caras, B Cohen, N S Young.   

Abstract

B19 parvovirus is the etiologic agent of fifth disease and transient aplastic crisis. In natural infections, B19 antigen and DNA have been detected in sera early in the course of aplastic crisis and only rarely in fifth disease. We have found B19 DNA in circulating cells of infected patients by DNA dot blot with a virus-specific probe: in four of four sickle cell patients with aplastic crisis, in one asymptomatic sibling, and in one normal adult with fifth disease. Only two of the sera showed B19 DNA. High-molecular weight intermediate forms were detected by Southern analysis of DNA extracted from cells, thus indicating active replication of virus in cells rather than passive adsorption to their surface membranes. Separation of cells into high- and low-density fractions resulted in a concentration of the virus DNA in the granulocytic fraction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833960

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow.

Authors:  H Baurmann; T F Schwarz; J Oertel; S Serke; M Roggendorf; D Huhn
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

3.  Severe bone marrow failure associated with human parvovirus B19 infection in a case with no underlying disorder.

Authors:  Chihiro Kawakami; Yukako Kono; Akiko Inoue; Kimitaka Takitani; Takayuki Ikemoto; Hiroshi Tamai
Journal:  Int J Hematol       Date:  2012-11-10       Impact factor: 2.490

4.  Parvovirus infection causing red cell aplasia and leukopenia in rheumatoid arthritis.

Authors:  A M Kamper; M Malbrain; P Zachee; S L Chew
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

5.  Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2.

Authors:  Yi Fu; Keiko Kumura Ishii; Yasuhiko Munakata; Takako Saitoh; Mitsuo Kaku; Takeshi Sasaki
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 7.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

8.  Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19.

Authors:  G Patou; D Pillay; S Myint; J Pattison
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Parvovirus B19-induced apoptosis of hepatocytes.

Authors:  Brian D Poole; Yuory V Karetnyi; Stanley J Naides
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Does parvovirus B19 have a role in rheumatoid arthritis?

Authors:  S Nikkari; R Luukkainen; T Möttönen; O Meurman; P Hannonen; M Skurnik; P Toivanen
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.